CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.
Weber S, Kehl V, Erber J, Wagner KI, Jetzlsperger AM, Burrell T, Schober K, Schommers P, Augustin M, Crowell CS, Gerhard M, Winter C, Moosmann A, Spinner CD, Protzer U, Hoffmann D, D'Ippolito E, Busch DH.
Weber S, et al. Among authors: d ippolito e, hoffmann d.
PLoS One. 2022 May 25;17(5):e0268530. doi: 10.1371/journal.pone.0268530. eCollection 2022.
PLoS One. 2022.
PMID: 35613127
Free PMC article.